arrow
S

Seigo Sugiyama

kurume university
H指数:62
被引数:1.4万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early Dose Escalation of Tirzepatide after Switching from Semaglutide in Type 2 Diabetes Mellitus

2型糖尿病 mellitus患者从Semaglutide转换后早期增加Tirzepatide剂量

2025-12-010
OAAI
Body Muscle-to-Fat Ratio (BMFR) as a Promising Anthropometric Index for Use in the Evaluation of Insulin Resistance and Metabolic Disease Risk: a Narrative Review

肌肉-脂肪比(BMFR)作为评估胰岛素抵抗和代谢疾病风险的潜在人体测量指标:一项叙事性综述

2025-10-290
OA
Long-term survival and treatment (tx) patterns after first-line (1L) osimertinib in patients (pts) with epidermal growth factor receptor (EGFR) mutation-positive (m) advanced non-small cell lung cancer (NSCLC): Japanese cohort of a global real-world (rw) observational study
2023-11-010
PRE
Changes in urinary glucose concentration and body weight in patients treated with the selective SGLT2 inhibitor luseogliflozin
2021-12-012
PREAI
Characteristics of nephropathy in severely obese Japanese patients complicated with type 2 diabetes mellitus: a cross-sectional cohort study

日本严重肥胖合并2型糖尿病患者的肾病特征: 一项横断面队列研究

2020-08-171
PREAI
Elevation of the renal threshold for glucose is associated with insulin resistance and higher glycated hemoglobin levels
2020-01-1516
OAAI
Body muscle-to-fat ratio gender-specific cut-off values for impaired insulin sensitivity in patients with treatment-naive type 2 diabetes mellitus
2019-10-195
PREAI
Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study
2018-12-0614
OAAI
Physiological Diagnostic Criteria for Vascular Failure
2018-11-01183
OAAI
Clinical usefulness of the body muscle-to-fat ratio for screening obstructive sleep apnea syndrome in patients with inadequately controlled type 2 diabetes mellitus
2018-09-017
PREAI
Dapagliflozin significantly reduced liver fat accumulation associated with a decrease in abdominal subcutaneous fat in patients with inadequately controlled type 2 diabetes mellitus
2018-08-0154
PREAI
Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes
2018-06-0185
OAAI
Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 diabetes mellitus
2018-05-0122
PREAI
Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study
2018-04-0647
OAAI
Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease
2017-12-0726
PREAI
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
2017-04-1229
OAAI
Colchicine Improves Survival, Left Ventricular Remodeling, and Chronic Cardiac Function After Acute Myocardial Infarction

秋水仙碱可改善急性心肌梗死后的生存率,左心室重塑和慢性心功能

2017-01-01100
OAAI
Prognostic significance of circulating leukocyte subtype counts in patients with coronary artery disease
2016-12-0138
PREAI
Correlation of body muscle/fat ratio with insulin sensitivity using hyperinsulinemic-euglycemic clamp in treatment-naive type 2 diabetes mellitus
2016-10-0124
PREAI
Lipid profile associated with coronary plaque regression in patients with acute coronary syndrome: Subanalysis of PRECISE-IVUS trial
2016-08-0122
PREAI